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Although >100 thiopeptides have been discovered,
the number of validated gene clusters involved in
their biosynthesis is lagging. We use genome mining
to identify a silent thiopeptide biosynthetic gene
cluster responsible for biosynthesis of lactazoles.
Lactazoles are structurally unique thiopeptides with
a 32-membered macrocycle and a 2-oxazolyl-6-thia-
zolyl pyridine core. We demonstrate that lactazoles
originate from the simplest cluster, containing only
six unidirectional genes (lazA to lazF). We show
that lazC is involved in the macrocyclization process,
leading to central pyridine moiety formation. Substi-
tution of the endogenous promoter with a strong
promoter results in an approximately 30-fold in-
crease in lactazole A production and mutagenesis
of lazC precursor gene in production of two analogs.
Lactazoles do not exhibit antimicrobial activity
but may modulate signaling cascades triggered by
bone morphogenetic protein. Our approach facili-
tates the production of a more diverse set of thio-
peptide structures, increasing the semisynthetic
repertoire for use in drug development.
INTRODUCTION
Microorganisms produce a large variety of ribosomally synthe-
sized and posttranslationally modified peptides (RiPPs). This
structurally diverse set of natural product macromolecules in-
cludes thiopeptides, linear azole/azoline-containing peptides
(LAPs), lanthipeptides, cyanobactins, and microcins (Arnison
et al., 2013). In RiPP biosynthesis, precursor peptide genes are
transcribed and translated into precursor peptides, which then
undergo posttranslational modification to form disulfides, dehy-
droamino acids, or heterocycles. Inmost cases, a leader peptide
in the N terminus of the precursor peptide is required for the
recruitment of modifying enzymes; this peptide is removed inChemistry & Biology 21,the final stage of biosynthesis. RiPPs exhibit a wide spectrum
of biological properties, including antimicrobial, anticancer,
and antiviral activities (Arnison et al., 2013). The modifications
of the peptide backbone confer bioactivity and stability and
also protect the peptides from proteolysis (Walsh and Nolan,
2008). The genetic encoding of RiPP precursor peptides can
be exploited by altering triplet sequences of codons in order to
make novel amino acid substitutions. This can be incorporated
into drug development strategies that use peptide compounds.
The Streptomyces genus is a rich source of RiPPs such
as thiopeptides, LAPs, lanthipeptides, and sactipeptides. Goad-
sporin, which is the only LAP isolated from actinomycetes, is
produced by Streptomyces sp. TP-A0584. This peptide, which
consists of 19 amino acids containing six azole rings and two de-
hydroalanines, promotes secondary metabolism and morpho-
genesis (Onaka et al., 2001). We previously identified the
goadsporin biosynthetic gene cluster of Streptomyces sp. TP-
A0584 (Onaka et al., 2005). This was the first example of an acti-
nomycete biosynthetic gene cluster for RiPPs that was capable
of producing both azole and dehydroamino acids. The god clus-
ter contains a class I lanthipeptide dehydratase homolog for de-
hydroalanine formation that is also found in all known thiopeptide
biosynthetic gene clusters.
Thiopeptides are produced mainly by actinomycetes and typi-
cally contain highly modified sulfur-containing peptides, which
have a characteristic macrocycle bearing a six-membered nitro-
gen-containing ring (e.g., pyridine or piperidine). During biosyn-
thesis of thiopeptides such as goadsporin, the precursor peptide
is modified to form dehydroalanines/dehydrobutyrines and
azole/azoline rings. Subsequently, the nitrogen-containing ring
is formed from two dehydroalanines in the core peptide via
cycloaddition (Bycroft and Gowland, 1978). Further tailoring
modifications lead to structural diversification of thiopeptides.
The majority of thiopeptides inhibit the growth of Gram-positive
bacteria, including methicillin-resistant Staphylococcus aureus
and vancomycin-resistant enterococci (Walsh et al., 2010).
To date, more than 100 thiopeptides have been discovered,
and several biosynthetic gene clusters have been identified
(Bagley et al., 2005; Li and Kelly, 2010). In addition, the progress
of genome sequencing techniques has triggered exponential
growth of genome databases, and numerous additional cryptic679–688, May 22, 2014 ª2014 Elsevier Ltd All rights reserved 679
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Figure 1. Gene Organization of the lazClus-
ter and Comparison with Other Thiopeptide
Biosynthetic Gene Clusters
Lactazole (laz), TP-1161 (tpa) (Engelhardt et al.,
2010), GE37468 (get) (Young and Walsh, 2011),
GE2270A (tpd_GE) (Morris et al., 2009), thio-
strepton (tsr) (Liao et al., 2009), cyclothiazomycin
(clt) (Wang et al., 2010), thiomuracins (tpd_TM)
(Morris et al., 2009), thiocillin (tcl) (Wieland Brown
et al., 2009), siomycin (sio) (Liao et al., 2009),
berninamycin (ber) (Malcolmson et al., 2013), no-
siheptide (nos) (Yu et al., 2009), nocathiacin (noc)
(Ding et al., 2010), and goadsporin (god) (Onaka
et al., 2005). The deduced functions are labeled
in color.
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A Minimum Gene Set for Thiopeptide Biosynthesisthiopeptide synthesis gene clusters have been identified in a
wide range of microorganisms (Li et al., 2012; Wieland Brown
et al., 2009). Recently, the development of convenient vectors
and host systems in the Streptomyces genus has facilitated
the identification of metabolites produced from several silent
gene clusters. However, there is no precedent for the identifica-
tion of thiopeptides from such clusters.
In this study, we identified a silent thiopeptide biosynthetic
gene cluster in the genome of Streptomyces lactacystinaeus
OM-6519, a lactacystin producer (Omura et al., 1991), and
isolated lactazole A, B, and C by heterologous expression in
Streptomyces lividans TK23. Lactazoles are structurally unique
thiopeptides that can be biosynthesized using only six unidirec-
tional genes spanning a 9.8-kb region of DNA. We discuss how
this concise biosynthetic gene cluster can be exploited to in-
crease the diversity and yield of thiopeptide analogs.
RESULTS
Genome Mining and Heterologous Expression of a
Cryptic Biosynthetic Gene Cluster for Thiopeptides
We used the sequence of godF, a class I lanthipeptide dehydra-
tase encoded by the goadsporin biosynthetic gene cluster, to
identify a putative thiopeptide biosynthetic gene cluster from
a draft genome sequence of S. lactacystinaeus OM-6519. This
cluster also contained the godD, godE, and godG homologs
that encode the enzymes of cyclodehydratase, nitroreductase,
and SpaB homolog, respectively; these enzymes are required
for dehydroalanine and azole synthesis. Additionally, a putative
precursor peptide gene was present in the upstream region.
Analysis of this region using FramePlot revealed that the cluster
contained six open reading frames (ORFs), which we later desig-
nated lazA, lazB, lazC, lazD, lazE, and lazF (Figure 1).680 Chemistry & Biology 21, 679–688, May 22, 2014 ª2014 Elsevier Ltd All rights reservedBecause S. lactacystinaeus OM-6519
did not produce metabolites related
to thiopeptides, we decided to transfer
the putative thiopeptide biosynthetic
gene cluster into S. lividans TK23 as
a surrogate host. We constructed a
pKU465cos-based cosmid library of the
S. lactacystinaeus OM-6519 genome
and isolated cosmid pKU465-ltc18-6C,
which contains the putative biosyntheticgene cluster. S. lividans TK23 was transformed with this cosmid
to generate S. lividans ltc18-6C. Comparative high-performance
liquid chromatography (HPLC) analysis of the fermentation
broth of S. lividans ltc18-6C and S. lividans transformed with
pKU465cos revealed a specific peak at 11.0 min that was pre-
sent only in the mutant strain (Figure 2).
Isolation and Structural Elucidation of Lactazoles
For large-scale preparation, mycelium collected from 3 l of
fermentation broth was extracted with methanol, followed by
two steps of liquid-liquid separation. Subsequently, size-exclu-
sion chromatography (LH-20), reverse-phase chromatography,
and preparative HPLC were performed to give pure compounds.
Finally, we isolated three thiopeptides, namely, lactazole A
(6.7 mg), lactazole B (2.7 mg), and lactazole C (0.7 mg).
Using high-resolution electrospray ionization mass spectrom-
etry (ESI-MS), 1H nuclear magnetic resonance (NMR), 13C NMR,
H-H correlated spectroscopy, H-H total correlation spectros-
copy, heteronuclear single quantum coherence (HSQC) spec-
troscopy, and heteronuclear multiple bond correlation (HMBC)
spectroscopy (Table S1 and Figure S3 available online), we
determined the chemical structure of lactazoles (Figure 3). The
major compound, lactazole A, showed m/z 1401.3975 [M+H]+,
indicating that the molecular formula is C61H64N18O16S3 (calcu-
lated 1,401.3788 [M+H]+). Abundant amide NH proton signals
(d 7.89–10.34) in 1H NMR spectra and carbonyl carbon signals
(d 158.85–173.91) in the 13C NMR spectra indicated a peptidic
structure. Four specific 1H signals (d 5.57–6.53) of two
methylenes and HMBC correlations to two relevant a carbons
(d 128.84 and 133.39) indicated two dehydroalanine residues.
Abundant 1H (d 8.34–8.71) and 13C (d 125.13–140.14) signals of
methines and HMBC correlations from those signals to relevant
quaternary carbons (d 139.72–173.24) indicated four azole rings.
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Figure 2. HPLC Traces of Lactazoles and
the Expression of Related Compounds in
Heterologous Hosts
(A) S. lividans ltc18-6C containing the whole laz
cluster.
(B) S. lividans KU465 harboring pKU465 as a
control.
(C) S. lividans DlazA, the lazA disruptant.
(D) S. lividans DlazC, the lazC disruptant.
(E) S. lividans S11C produces the Ser11Cys
analog.
(F) S. lividans W2S produces the Trp2Ser analog.
(G) S. lividans pTYM1ga containing pTYM1ga as a
control.
HPLC conditions and sample preparation are
described in Experimental Procedures. The
elution peaks with arrows indicate the lactazole A
(A), a compound accumulated in DlazC (D), S11C
(E), and W2S (F), respectively.
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A Minimum Gene Set for Thiopeptide BiosynthesisTwo methine signals (1H d 8.11 and 7.37, 13C d 118.18 and
138.35) and HMBC correlations to quaternary carbons (d
131.80–167.31) and carbonyl carbon (d 166.74) indicated trisub-
stituted pyridine. 1H signal (d 10.82) of NH and HMBC correla-
tions to carbons (d 110.17, 123.65, 127.37, and 136.09) in the
indole of tryptophan were detected. HMBC correlations also
indicated that tryptophan is attached to 3-position of pyridine.
The chemical structure of lactazoles exactly matched the
deduced amino acid sequence of the C-terminal region of the
putative precursor peptide. These spectrum analyses revealed
that lactazole A is an 11-amino acid macrocyclic thiopeptide
containing one oxazole, three thiazoles, two dehydroalanines,
and a 2,3,6-trisubstituted pyridine. Oxazole, tryptophan, and
thiazole attached at the pyridine 2-, 3-, and 6-positions, respec-
tively. Mass spectrometry (MS)/MS fragment patterns were
consistent with the structure elucidated from NMR analysis.
We also detected twominor analogs, lactazole B and C, which
hadsimilarUV-visible spectrumsonHPLC-photodiodearray (Fig-
ure S3). ESI-MS analysis showedm/z 1,529.4586 [M+H]+ for lac-
tazole B and m/z 1,176.2830 [M+H]+ for lactazole C, indicating
molecular formulas of C66H72N20O18S3 (calculated 1,529.4547
[M+H]+) and C51H49N15O13S3 (calculated 1,176.2875 [M+H]
+),
respectively (Figure S3). These results indicate that lactazole B
has an additional glutamine residue (128.0 Da) at the C terminus
compared with lactazole A, whereas lactazole C lacks the C-ter-
minal glutamine and proline residues (225.2 Da) that are found in
lactazole A (Figure 3).MS/MSanalysis confirmed the existence of
an additional glutamine for lactazole B and the absence of gluta-
mine and proline in the C terminus of lactazole C (Figure S3). The
Chemical Abstracts Service database did not contain any com-
pounds related to lactazole A, B, and C.
Determination of the Lactazole Biosynthetic Gene
Cluster Region
To identify the essential gene set required for lactazole biosyn-
thesis, we conducted subcloning and gene disruption experi-
ments (Figure S2). S. lividans ltc6C07, which harbors the
13.6-kb KpnI and TasI fragment that catalyzes lactazole pro-
duction, was used. Subsequently, ltc74 and ltc66, which are
located in the flanking regions at either end of this cluster,
were disrupted. Lactazoles were still produced by both Dltc74Chemistry & Biology 21,and Dltc67 S. lividans mutants, suggesting that these gene
products were not required for the biosynthesis. To confirm
that we had identified the essential gene set, we PCR-cloned
only lazA to lazF and expressed these six genes in S. lividans
TK23. The derivative strain, S. lividans lazAF, produced lacta-
zoles, and we thus conclude that these six genes are sufficient
for lactazole biosynthesis.
lazA encodes a 57 amino acid precursor peptide with no ho-
mology to other published sequences (Figure 4). LazB shares
similarity with GodF (identity 23.5%), which is known as a lanti-
biotic-type dehydratase. LazE is similar to GodD (identity
22.1%) and contains a C-terminal YcaO domain; the protein is
a putative cyclodehydratase required for azoline formation.
LazF is composed of an N-terminal lantibiotic dehydratase
domain and a C-terminal flavin mononucleotide-dependent de-
hydrogenase domain; the N-terminal domain shares homology
with GodG, while the C terminus is similar to that of GodE. This
observation may suggest that LazF functions as a bifunctional
enzyme that can catalyze both dehydroalanine formation and
azoline dehydrogenation. We could not assign any function to
LazC and LazD on the basis of a sequence homology search.
Because all posttranslational modifications except for macro-
cyclization could be assigned to LazB, LazE, and LazF, we
assumed that LazC and/or LazDmight be involved in the macro-
cyclization step (Table 1).
Although we conducted a series of genetic disruption experi-
ments to dissect the lactazole biosynthetic pathway, lactazoles
and related compounds could not be detected in the fermenta-
tion broth when lazA, lazB, lazD, lazE, or lazF was disrupted (Fig-
ure S2). By contrast, a newHPLC peak at 11.3 min was identified
in the extract of the fermentation broth of the lazC deletion strain
(S. lividansDlazC) (Figure 2). MS analysis of the peak showedm/z
1,437.4150 [M+H]+ (Figure S3), indicating a molecular formula of
C61H68N18O18S3 (calculated 1,437.4199 [M+H]
+).
Structural Elucidation of the Products from the lazC
Deletion Strain
The product corresponding to m/z 1,437.4150 [M+H]+
(1,437.4194 calculated for C61H69N18O18S3) of lazC disruptant
was purified for structural elucidation. Mycelium from 2.4 l of
fermentation broth was extracted with methanol, followed by679–688, May 22, 2014 ª2014 Elsevier Ltd All rights reserved 681
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Figure 3. Chemical Structures of the Com-
pounds Isolated in This Study
(A) Lactazole A, B, and C.
(B) A compound that accumulates in the DlazC
mutant.
(C) Lactazole analogs, S11C and W2S.
Asterisks indicate the amino acid residues that are
posttranslationally modified.
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A Minimum Gene Set for Thiopeptide Biosynthesislactazole purification, which yielded 2.5 mg of pure compounds.
NMR and MS analyses revealed that this compound was
fully modified, linear, and proteolyzed to 15 residues, as was
observed for lactazole A (Figure 3).
The product lacked the two proton signals derived from the
central pyridine (8.11 and 7.37 ppm in lactazole A; Table S1),
suggesting that this compound did not undergo macrocycliza-
tion and retained a linear structure. The loss of UV absorbance
around 325 nm supported this idea (Figure S3). Similar observa-
tions were reported following studies of thiocillin biosynthesis,
as the linear variants of thiocillin produced by a tclM deletion
strain lacked the absorbance around 350 nm (Bowers et al.,
2010).
Instead of a signal indicative of a central pyridine, three pairs
of signals corresponding to dehydroalanine residues were
observed at 6.24 and 5.75 ppm (Dha6), 5.90 and 5.85 ppm
(Dha10), and 6.18 and 5.75 ppm (Dha12) in the 1H NMR
spectrum. Correlations between HSQC and HMBC spectra
confirmed the presence of three dehydroalanines (Figure S3).
In addition to an additional dehydroalanine, a characteristic
methyl proton at 2.20 ppm was observed as a singlet. In the
HMBC spectrum, this methyl signal was correlation with two
carbonyl signals at 196.9 and 161.3 ppm. These observations682 Chemistry & Biology 21, 679–688, May 22, 2014 ª2014 Elsevier Ltd All rights reservedsuggested the presence of an N-terminal
methyl ketone moiety. This is likely to
be derived from tautomerization and
hydrolysis of the N-terminal dehydroala-
nine residue, indicating that Ser1, Ser6,
Ser10, and Ser12 had already been
processed to dehydroalanines in the
product that accumulated in the lazC
disruptant.
Signals corresponding to three thia-
zoles and one oxazole could also be as-
signed in one-dimensional and 2D NMR
spectra. MS/MS fragmentation analysis
and the chemical shifts observed in 1H
NMR and 13C NMR are summarized in
Table S1.
Bioactivity of Lactazoles
Lactazoles did not show any antimicro-
bial activities against the strains tested
in this study. In paper disc assays, lacta-
zoles did not inhibit the growth of
S. aureus FDA209P JC-1, Bacillus subtilis
ATCC6633, S. lividans TK23, Micro-
coccus luteus ATCC9341, Escherichia
coli NIHJ JC-2, Saccharomyces cerevi-siae S100, Candida albicans A9540 and Penicillium chrysoge-
num NBRC6223.
However, during screening of compounds that could be used
for treatment of fibrodysplasia ossificans progressiva (Fukuda
et al., 2012), we found that the alkaline phosphatase activity of
osteoblastic C2C12 (R206H) cells was reduced by treatment
with lactazoles. The half maximal inhibitory concentration values
for lactazole A, B, and C were 101, 116, and 93.5 mM, respec-
tively, and no cytotoxicity was observed at doses up to 200 mg
ml1. This result suggests that molecular targeting of lactazoles
could modulate signaling cascades triggered by bone morpho-
genetic protein.
Enhanced Lactazole A Production via Genetic
Engineering
The laz cluster is 9.8 kb, and all laz genes are ordered in the same
orientation without apparent internal gaps (Figure 1). This organi-
zation suggests that the lazA promoter drives expression of the
entire laz gene cluster. The yield of lactazole from this cluster
was 12.9 mg l1, whereas the yield of goadsporin from the clus-
ter driven by the godA promoter was 342.7 mg l1 (H.O., unpub-
lished data). Thus, we reasoned that lactazole production would
be increased by substitution of the lazA promoter with the godA
core peptide a 
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Figure 4. Phylogenetic Analysis of the Core Peptide Amino Acid Sequences and Comparison with Various Thiopeptides and Goadsporin
aAlignment of the core peptide amino acid sequences is shown. Color coding: red, serine; blue, cysteine; green, threonine. Amino acid residues that participate in
the formation of the main ring containing the central N-containing heterocyclic domain are underlined. The C-terminal cleavage sites in lactazole, GE37468,
thiomuracin, and GE2270A are indicated by hyphens. The core peptides in goadsporin (GodA) (Onaka et al., 2005) and in thiopeptide precursors, lactazole (LazA),
GE2270A (TpdA_GE) (Morris et al., 2009), GE37468 (GetA) (Young and Walsh, 2011), thiomuracins (TpdA_TM) (Morris et al., 2009), TP-1161 (TpaA) (Engelhardt
et al., 2010), berninamycin (BerA) (Malcolmson et al., 2013), cyclothiazomycin (CltA) (Wang et al., 2010), thiocillin (TclE-H) (Wieland Brown et al., 2009), siomycin
(SioH) (Liao et al., 2009), thiostrepton (TsrH) (Liao et al., 2009), nosiheptide (NosM) (Yu et al., 2009), and nocathiacin (NocM) (Ding et al., 2010), are shown.
bThe number of macrocycles in thiopeptides is shown, with the number of amino acid residues that form the macrocycle given in parentheses (submacrocycles
bridged by sulfide, quinaldic acid, and indole are indicated by s, q, and i, respectively).
cSer, Thr, and Cys (SCT) ratios in the core peptides are shown. The ratios except for C-terminal cleavage amino acids in lactazole A, GE37468, thiomuracin, and
GE2270A are given in parentheses.
dPutative precursor sequences proposed from the chemical structures (Engelhardt et al., 2010).
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A Minimum Gene Set for Thiopeptide Biosynthesispromoter. As predicted, the amount of lactazole A in S. lividans
gp-lazAF, in which expression of the laz cluster is driven by the
godA promoter, reached 383.8 mg l1 (Figure 5).
Production of Lactazole A Analogs by Amino Acid
Substitution
To assess whether the posttranslational modification enzymes
could tolerate analogs, we performed a systematic site-directed
mutagenesis of the lazA precursor gene. For the analog produc-
tion, we constructed the pTYM1gp+lazA plasmid for precursor
peptide (lazA) overexpression and the pTYM19 gp+lazBF
plasmid for expression of the enzymes that mediate posttransla-
tional modifications (lazB to lazF operon). Both plasmids are co-
integrated into chromosomal DNA and are under control of the
godA promoter. We then performed two separate site-directed
mutagenesis reactions of lazA that led to the expression
of Ser11Cys and Trp2Ser analogs in the relevant S. lividans
transformant (Figure 2). The fermentation broth of S. lividans
Ser11Cys contained a specific product corresponding to m/zChemistry & Biology 21,1417.3788 [M+H]+ that had a molecular mass of 16.0 Da more
than that of lactazole A, indicating the replacement of oxygen
with sulfur. The molecular weights and MS fragmentation anal-
ysis (Figure S3) indicated the production of the lactazole analog
Ser11Cys, which has a thiazole instead of an oxazole at the 2-
position of the central pyridine (Figure 3). Trp2Ser showed m/z
1302.3478 [M+H]+ (1302.3510 calculated for C53H60N17O17S3).
The result of MS fragmentation analysis (Figure S3) suggested
that the Trp2Ser analog can still be converted to a macrocyclic
ring, despite the significant change in amino acid structure
(Figure 3).
DISCUSSION
Here, we used a genome mining of the S. lactacystinaeus OM-
6519 sequence to identify a cryptic thiopeptide biosynthetic
gene cluster. Phylogenetic analysis of thiopeptide precursor
peptides revealed that the LazA core peptide did not belong
to an existing clade, suggesting that the lazA locus evolved679–688, May 22, 2014 ª2014 Elsevier Ltd All rights reserved 683
Table 1. Deduced Genes and Their Proposed Functions in laz Cluster and the Surrounding Region
Gene
Amino
Acid Putative Function Pfam Prediction Homologous Gene (Origin) Identity (%)
Accession
Number
ltc74 857 – ND serine/threonine protein kinase
(S. griseus XylebKG-1)
50 ZP_08233747
lazA 57 precursor peptide – – –
lazB 880 Dha formation lantibiotic dehydratase,
N terminus
lantibiotic dehydratase,
C terminus
godF (Streptomyces sp. TP-A0584) 20 BAE46921
tsrJ (S. laurentii ATCC 31255) 25 ACN80672
lazC 406 [4+2] cycloaddition – tclM (B. cereus ATCC 14579) 12 AE016877
lazD 565 unknown – – – –
lazE 688 azoline formation YcaO-like family godD (Streptomyces sp. TP-A0584) 21 BAE46919
sioO (S. sioyaensis ATCC 13989) 28 ACN80652
lazF 557 Dha formation (11-288) SpaB C-terminal domain godG (Streptomyces sp. TP-A0584) 19 BAE46922
azole formation (362-547) nitroreductase family godE (Streptomyces sp. TP-A0584) 26 BAE46920
ltc66 117 – ND peptidase S24/S26A/S26B, conserved
region (Niastella koreensis GR20-10)
33 AEW02165
ltc65 275 – ND creatininase (Polymorphum gilvum
SL003B-26A1)
46 YP_004304855
ND, not determined.
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(Figure 4). Indeed, in LazA, the proportion of posttranslationally
modified serine/threonine/cysteine residues is the lowest
(56%) among the known thiopeptide families. Furthermore, the
primary sequence of the LazA core peptide contains tryptophan
and glutamine residues, which to date have never been found in
natural thiopeptides. The unique genomic context and associ-
ated peptide sequence drove us to characterize the metabolites
derived from this cryptic biosynthetic gene cluster. Strikingly,
this cluster only produces a unique class of thiopeptides, the
lactazoles, when expressed in an alternate host bacterial strain,
S. lividans TK23.
Unexpectedly, lactazoles were composed of a macrocyclic
ring of 11 amino acids. This is unusual, because all other macro-
cycles found in thiopeptides are 9, 10, or 12 amino acids in
length. Thus, the lactazole ring addsmore diversity to themacro-
cycle framework. In addition, the 2-oxazolyl-6-thiazolyl pyridine
core, in which the 3-position is connected to the bulky trypto-
phan side chain by an amide linkage, is also a structure unique
to lactazole. Typically, 2,3,6-trithiazolylpyridine core is known
in thiopeptides. Although some atypical substitution patterns,
such as 2-oxazolyl-3-thiazolylpyridine in berninamycin and TP-
1161 and 6-thiazolylpyridine in cyclothiazomycin, have also
been isolated, 2-oxazolyl-6-thiazolyl pyridine moiety was clearly
different from known examples. Additionally, we found that the
length of the C terminus varies between the lactazole B andC an-
alogs. This C-terminal chain length diversity is also not observed
in other thiopeptides, and we suggest that it may be due to pep-
tidases present in the heterologous host.
Most thiopeptides have growth-inhibitory activity against
Gram-positive bacteria (Bagley et al., 2005). However, lactazoles
did not exert such effects against any of the microorganisms we
tested. We found that the alkaline phosphatase activity of oste-
oblastic C2C12 (R206H) cells was reduced following lactazole
treatment, suggesting that the molecular target(s) of lactazoles684 Chemistry & Biology 21, 679–688, May 22, 2014 ª2014 Elseviermay be involved in bone morphogenetic protein signaling cas-
cades in vivo. Identification of the precise targets will shed light
on the potential antibiotic utility of this novel thiopeptide family.
The compact genomic organization of the lactazole biosyn-
thetic cluster makes it highly amenable to genetic manipulation;
indeed, the whole cluster can be amplified by a single round of
PCR. This conciseness can be explained by the lack of apparent
intergenic regions. Among the six genes, lazB, lazC, lazD, and
lazE are translationally coupled, while the lengths of the inter-
genic regions between lazA and lazB and between lazE and
lazF are 221 and 80 bp, respectively. We aimed to improve lac-
tazole production by replacing the single promoter upstream
of lazA with the godA promoter, because we have previously
shown that this promoter drives high levels of goadsporin pro-
duction (342.7 mg l1) (H.O., unpublished data) in S. lividans
TK23. Indeed, the strain with the godA promoter substitution
produced 383.8 mg 11 of lactazole A upon culture, which is a
29.8-fold increase compared with the original strain.
Because promoter substitution gave a high yield of production
in S. lividans TK23, we further examined whether analogs could
be produced using this system. To evaluate the substrate spec-
ificities of tailoring enzymes, we focused on the substitution of
neighboring residues of the central pyridine core, which led to
the production of the two analogs, S11C andW2S. The chemical
structure of the S11C substitution was transformed from oxazole
to thiazole; however, the W2S substitution was not converted to
oxazole. Together, these data suggest that the enzyme required
for azole ring formation is regiospecific.
The macrocyclization step during thiopeptide biosynthesis
is challenging to reproduce biochemically, and the associated
mechanistic steps remain. Our gene disruption experiments re-
vealed that lazC is responsible for the pyridine ring formation,
because the product of lazC disruptant is linear, and the N-termi-
nal serine residue was replacedwith amethyl ketone. The forma-
tion of the methyl ketone would likely occur through a primaryLtd All rights reserved
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Figure 5. Lactazole Production by Promoter Substitution of laz
Cluster in GS and A-3M Media
S. lividans Ltc6C07: laz cluster expressed under original promoter. S. lividans
gp-lazAF: laz cluster expressed under godA promoter. Seven day culture broth
was measured. Each value is the mean ± SD of triplicate values from a
representative experiment.
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tautomerization and subsequent spontaneous hydrolysis.
Similar linear peptides have been detected following gene
disruption within other biosynthetic clusters, such as those that
produce thiocillin, GE2270. The onlymechanistic insight into pyr-
idine ring formation in thiopeptide biosynthesis was provided
following disruption of tclM in the thiocillin biosynthetic gene
cluster (Bowers et al., 2010). TclM, a putative Diels-Alderase, is
conserved in the gene cluster for macrocyclic thiopeptide and
does not exist in the acyclic goadsporin gene cluster. Disruption
of tclM resulted in the accumulation of a linear compound con-
taining an N-terminal methyl ketone moiety, suggesting that
TclM catalyzes [4+2] cycloaddition between the two dehydroala-
nines. Despite very low similarity between lazC and tclM (Fig-
ure S1), disruption of lazC also led to the accumulation of a linear
compound that has properties similar that isolated from the tclM
mutant. Similar structures, namely, linear polypeptides with a
methyl ketone moiety at the N terminus, were observed in
biosynthetic intermediate derivatives of GE2270 from Planobis-
pora rosea (Tocchetti et al., 2013). In this latter case, the authors
concluded that insufficient maturation of the C terminus pre-
vented completion of the macrocyclization step, which led to
the accumulation of linear compounds. However, our current
study revealed that the products that accumulate in the lazC
deletion strains were mature but simply had not undergone
macrocyclization. On the basis of these results, we conclude
that LazC catalyzes the Diels-Alder condensation at the last
step of posttranslational modification in a manner similar to
TclM. Linear compounds with highly matured structures were
also isolated in berninamycin biosynthesis by precursor peptides
mutations. This also provided insight into late-stage macrocycli-
zation event (Malcolmson et al., 2013).
Consistent with earlier studies of thiopeptide biosynthesis
(Ding et al., 2010; Liao et al., 2009), disruption of laz genes abol-
ishes lactazole production and prevents product accumulation.
Specifically, our disruption studies confirmed the involvement
of lazB, lazD, lazE, and lazF in the lactazole biosynthesis. Bio-
informatic analyses predicted that LazB, LazE, and LazF prod-
ucts were responsible for the formation of dehydroalanine and
thiazole/oxazole. On the other hand, the lack of sequence simi-Chemistry & Biology 21,larity of LazDwith any of the known enzymes involved in thiopep-
tide biosyntheses precluded the assignment of a function for
this protein (Table 1). It is possible that this enzyme cleaves the
leader peptide of the matured precursor; in this scenario, the
resulting linear core peptide would be a suitable substrate for a
macrocyclization reaction possibly catalyzed by LazC.
On the basis of the chemical structures of lactazoles, the gene
annotation, and our gene disruption experiments, we propose
the lactazole biosynthetic pathway shown in Figure 6. In the first
step, the lazA gene is transcribed and then translated into the
precursor peptide by the ribosome. Although the order of dehy-
droalanine and azole ring formation is still unknown, Ser1, Ser6,
Ser10, and Ser12 in the precursor peptide will be modified
into dehydroalanines by LazB, a lantibiotic-type dehydratase,
whereas Cys5, Cys7, and Cys13 will be converted to thiazoles,
and Ser11 will be converted into an oxazole by the activities of
LazE (a cyclodehydratase) and LazF (a dehydrogenase). It is
likely that N-terminal leader peptide cleavage then occurs,
followed by a hetero-Diels-Alder condensation between Dha1
and Dha12 catalyzed by LazC. However, this model is still
incomplete, as the true function of LazD remains obscure.
The lactazoles we isolated in this study contain unusual
structural features. Even though more than 100 thiopeptides
have been discovered since 1948, only three types of macrocy-
clic rings, with 26, 29, or 35 atoms, have been isolated. Here
we found a 32-membered macrocyclic ring formed by 11 amino
acid residues that bridged the missing link of macrocyclic ring
size. Additionally, the 2-oxazolyl-6-thiazolyl pyridine core, with
the 3-position connected to tryptophan through an amide link-
age, provides a core structure that is different from those of
known thiopeptides. Our report demonstrates that genome
mining is a powerful strategy that can be applied to uncover
biosynthetic pathways for natural drug products. The ability
to engineer these compact biosynthetic clusters to produce
diverse groups of thiopeptide analogs with distinct bioactivities
bodes well for the future of natural product-based drug
discovery.
SIGNIFICANCE
Thiopeptides are one of themajor groups among the natural
antimicrobial products that are biosynthesized by ribo-
somal translational machinery. In this study, we found the
simplest thiopeptide biosynthetic gene cluster from the
S. lactacystinaeus OM-6519 genome. Although the biosyn-
thetic gene cluster was silent in the original strain, transfer
of the cluster toS. lividans TK23 led to the synthesis of struc-
turally unusual thiopeptides, lactazoles. Currently, the ring
size of macrocyclic thiopeptide is limited to 26, 29, or 35
atoms. A 32-membered ring of lactazoles expands the struc-
tural possibility of thiopeptides. The 2-oxazolyl-6-thiazolyl
pyridine core with the 3-position connected to tryptophan
through an amide linkage also provides a unique core
structure in thiopeptides. The formation of this unique 32-
memberedmacrocycle would be catalyzed by LazC. Consis-
tent with its structural uniqueness, the precursor peptide
sequence was classified into a phylogenetically distinct
clade. Unexpectedly, we found that the lactazoles do
not have any antimicrobial activity; instead, they possess679–688, May 22, 2014 ª2014 Elsevier Ltd All rights reserved 685
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signal cascade in vivo, which could direct thiopeptide family
antibiotics to a new aspect of therapeutic treatment.
The lactazole biosynthetic gene cluster consists of only
six unidirectional genes. It is the smallest cluster among
the known thiopeptide biosynthetic gene clusters. The sub-
stitution of the endogenous promoter with that of godA,
a gene involved in goadsporin biosynthesis, led to a 29.8-
fold increase in the production of lactazole A. Using the
godA promoter to regulate the lactazole biosynthetic
machinery, production of two analogs, S11C and W2S, was
achieved. Thus, this compact biosynthetic machinery has
high potency to lend large diversity to the thiopeptide core
structures.
EXPERIMENTAL PROCEDURES
GenomeMining and Cloning of Lactazole Biosynthetic Gene Cluster
Draft genome sequencing of S. lactacystinaeus OM-6519 was performed
using an Illumina GA-II instrument (Illumina). De novo assembly of sequence
data was performed using Velvet software version 0.7.18. We identified
thiopeptide biosynthetic gene cluster from genome of S. lactacystinaeus
OM-6519, which was found by local BLAST search using godF, godD, and
godG as the queries.
ORFs were deduced from the sequence with the assistance of FramePlot
4.0 beta software (Ishikawa and Hotta, 1999). The corresponding deduced
proteins were compared with other known proteins in the databases using
available BLAST methods (http://www.ncbi.nlm.nih.gov/blast). Amino acid
sequence alignments were performed with CLUSTALW from the DNA Data
Bank of Japan (DDBJ) (http://www.ddbj.nig.ac.jp/index-j.html).
For S. lactacystinaeus OM-6519 cosmid library, the genomic DNA was
digested with Sau3AI and ligated into the BamHI site of pKU465cos (Komatsu
et al., 2010). Packaging and transformation into E. coli DH5a were done
with l-packaging mixtures. pKU465-ltc18-6C including laz gene cluster
was acquired by PCR screening using two sets of primers, LTC11_73_F
and LTC11_73_R, and LTC11_67 godE&G_F and LTC11_67 godE&G_R.
pKU465-ltc18-6C was transformed into S. lividans TK23 to generate
S. lividans ltc18-6C.686 Chemistry & Biology 21, 679–688, May 22, 2014 ª2014 Elsevier Ltd All rights reservedSample Preparation and HPLCDetection of
Lactazoles
Each strain was inoculated into test tubes contain-
ing 10ml of V-22medium. After incubation at 30C
for 2 days on a rotary shaker at 200 rpm, 3 ml cul-
tures of the seed culture were transferred into
500 ml K-1 flasks (Preci) containing 100 ml of A-
3M or goadsporin (GS) medium. Fermentation
was carried out at 30C, 200 rpm, for more than
5 days on the rotary shaker. The 4 ml whole-
fermentation broths were extracted with 5 ml
n-butanol. After evaporation of the n-butanol, the
residue was dissolved in DMSO. HPLC analysis
(Figures 2A–2D) was performed with an HP1100
(Hewlett-Packard) system using a C18 Rainin Mi-
crosorb column (3 mm, 4.6 mm inside diameter 3
100 mm length; Rainin Instrument). MeCN,
0.15% KH2PO4 (pH 3.5), was used as elutionbuffer. The column temperature was 40C, the flow rate was 1.2 ml min1,
and detection was performed at 254 nm. The MeCN concentration was kept
at 15% for the first 3 min, linearly increased to 85% for the next 22 min, and
kept at 85% for the next 4min. Lactazoles were identified on the basis of reten-
tion times, UV spectra, andmolecular mass. Chromatograms in Figures 2E–2G
were obtained using an ion-trap liquid chromatography (LC)-MS system
equipped with a Cosmosil 5C18 AR-II column (5 mm, 2.0 mm inside
diameter 3 150 mm length; Nacalai Tesque). MeCN and 0.1% HCOOH were
used as eluents. The column temperature was 40C, the flow rate was
0.3 ml min1, and detection was performed at 254 nm. The MeCN concentra-
tion was kept at 5% for the first 2 min, linearly increased to 95% over the next
25 min, and kept at 95% for the next 5 min.
Purification of Lactazoles and a DlazC Disruptant Product
After fermentation, the fermentation broth (3 l) was centrifuged at 8,000 rpm for
10 min. The supernatant was discarded, and the mycelial cake was extracted
with 3 l of methanol three times. The mixture was centrifuged at 8,000 rpm
for 10 min, and the methanol layer was separated from the mycelial cake.
After evaporation to remove methanol, the resultant aqueous solution was
partitioned between 60% aqueous methanol and CH2Cl2. The 60% aqueous
methanol-soluble fraction was evaporated and partitioned between H2O and
n-butanol. Evaporation of the n-butanol-soluble fraction gave approximately
1.6 g of extract. A fraction recovered by solving in DMSO was subjected to
Sephadex LH-20 gel filtration chromatography using methanol-CH2Cl2 (1:1)
as eluent, and aliquots of each fraction were analyzed by HPLC described
above. After the fractions containing lactazoles were combined and evapo-
rated (200 mg), further purified by reverse-phase octadecylsilyl (ODS)
(75 mm, Cosmosil 75C18-PREP; Nacalai Tesque) column chromatography
with a step gradient of acetonitrile/H2O (2:8, 3:7, 4:6, 5:5, 6:4, 7:3, and
8:2 v/v). The fractions containing lactazoles were combined (49 mg) and
then purified by reverse-phase HPLC (1200 series; Agilent Technologies) sys-
tem using Cosmosil 5PE-MS (5 mm, 10mm inside diameter3 250mm [Nacalai
Tesque], 4 ml min1, detection at 254 nm) with a gradient elution from 25% to
50% of 0.1% HCOOH buffer with MeCN over 30 min to give lactazole A
(6.7 mg), B (2.7 mg), and C (0.7 mg). For the purification of a DlazC product,
the mycelial cake from 2.4 l fermentation broth was extracted by methanol
as described above. The methanol fraction was washed by hexane and recov-
ered. The recovered fraction was partitioned between 60% aqueous methanol
and CH2Cl2. The 60% aqueousmethanol-soluble fraction was evaporated and
partitioned between H2O and n-butanol. Evaporation of n-butanol-soluble
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A Minimum Gene Set for Thiopeptide Biosynthesisfraction gave approximately 4.2 g of extract. A fraction recovered by solving in
DMSOwas separated by Sephadex LH-20 gel filtration chromatography using
the method described above. The fractions containing lactazoles were com-
bined and evaporated (240 mg), further purified by reverse-phase ODS
(75 mm, Cosmosil 75C18-PREP) column chromatography with a step gradient
of acetonitrile/H2O (1:9, 2:8, 3:7, 4:6, and 10:0 v/v). The fractions containing
lactazoles were combined (48 mg) and then purified by reverse-phase
HPLC (L-2000 system; Hitachi) using Xterra Prep RP18 (5 mm, 10 mm inside
diameter3 150mm [Waters], 3mlmin1, detection at 254 nm) with an isocratic
elution by 73% of 10 mM NH4HCO3 buffer with MeCN over 30 min to give a
purified compound.
Structure Elucidation of Lactazoles
NMR spectra were obtained with a Bruker AVANCE 500 spectrometer at 500
MHz for 1H and 125 MHz for 13C using residual solvent (DMSO-d6) peaks at
dH 2.49 and at dC 39.8 ppm as chemical shift reference signals. Exact MS
was performed on a time-of-flight instrument (Xevo G2-S Tof; Waters) inter-
faced to an ultraperformance liquid chromatograph (ACQUITY; Waters) oper-
ating in MSE mode with positive electrospray ionization mode. NMR spectra
of a DlazC product were obtained with an ECA-600 (JEOL) spectrometer
at 600 MHz for 1H and 150 MHz for 13C NMR. MS/MS and MS/MS/MS
analyses were performed on an ion-trap instrument (amaZon SL; Bruker Dal-
tonics) interfaced to an HPLC system (Agilent Technologies 1200 series)
operating in MS/MS and MS/MS/MS mode with positive electrospray ioniza-
tion mode.
Subcloning of laz Gene Cluster
(1) pTYM19-ltc6C07: pKU465-ltc18-6C was digested with BamHI, and the re-
sulting 11.9-kb fragment was cloned into the BamHI site of pTYM19, which is
an actinomycetes-E. coli integrating vector (Onaka et al., 2003b), to generate
pTYM19-ltc6C01. pKU465-ltc18-6C was digested with KpnI and PstI, and the
resulting 6.8-kb fragment was cloned into the KpnI and PstI site of pTYM19 to
generate pTYM19-ltc6C02. pTYM19-ltc6C01 was digested with PstI, and the
resulting 9.9-kb fragment was subcloned into the PstI site of pTYM19-ltc6C02
to generate pTYM19-ltc6C03. pTYM19-ltc6C03, which has a 16.8-kb region
including laz cluster from pKU465-ltc18-6C, was digested with EcoRI and
TasI, and the resulting 13.6-kb fragment was subcloned into the EcoRI site
of pTYM19 to generate pTYM19-ltc6C07. (2) pTYM19-lazAF: The fragment
from upstream of lazA to downstream of lazF was amplified as a 10.7-kb
DNA fragment by PCR, using pTYM19-ltc6C03 as the template and two
primers, ltc73+pro-F-EcoRI and ltc68-down-3-EcoRI-2. The PCR-generated
fragment containing the laz cluster was cloned into the EcoRI sites of
pTYM19 to generate pTYM19-lazAF. The new junction regions in the con-
structed plasmids were confirmed by direct sequencing.
Construction of the Strains for Gene Inactivation of lazA, lazB, lazC,
lazD, lazE, lazF, ltc74, and ltc66
For the in-frame deletion of lazA, lazB, lazC, lazD, lazE, lazF, ltc74, and ltc66,
the method of insertional inactivation by a double crossover was performed.
The 2.0-kb upstream and downstream regions of those genes were PCR
amplified. The resulting fragments were digested with EcoRI and XbaI and
ligated into the EcoRI sites of pTYMdis (Onaka et al., 2005) to give
pTYMdis-lazA, pTYMdis-lazB, pTYMdis-lazC, pTYMdis-lazD, pTYMdis-
lazE, pTYMdis-lazF, pTYMdis-ltc74, and pTYMdis-ltc66. pTYM19Xint was
constructed from pTYM19 (Onaka et al., 2003b) by the deletion of
4C31int*. pTYM19 was digested with NcoI and XhoI, and the resulting larger
fragment was converted to a blunt-ended molecule and self-ligated to
generate pTYM19Xint. pTYMdis-lazA, pTYMdis-lazD, pTYMdis-lazE,
pTYMdis-lazF, and pTYMdis-ltc74 were digested with EcoRI, and the result-
ing 4.0-kb fragments were subcloned into the EcoRI site of pTYM19Xint to
generate pTYM19X-lazA, pTYM19X-lazD, pTYM19X-lazE, pTYM19X-lazF,
pTYM19X-ltc74. The generated plasmids were confirmed by digestion with
appropriate restriction enzyme(s) and DNA sequencing using For and
RV primers. The gene disruption procedure was as described previously
(Onaka et al., 2003a). In-frame disruptants, S. lividans ltc18-6CD74, ltc18-
6CDlazA, ltc18-6CDlazB, ltc18-6CDlazC, ltc18-6CDlazD, ltc18-6CDlazE,
ltc18-6CDlazF, and ltc18-6CD66, were generated using pTYMdis derivatives
or pTYM19Xint derivatives.Chemistry & Biology 21,lazAwas PCR amplified using LTC73-F-NdeI and LTC73-R-XbaI. The result-
ing 0.4-kb fragment was digested with NdeI and XbaI and cloned into the NdeI
and XbaI sites, downstream of godA promoter, of pTYM1ga to generate
pTYM1ga-lazA.
Bioactivity of Lactazoles
Bioactivity of lactazoles against the eight indicator strains, S. aureus FDA209P
JC-1, B. subtilis ATCC6633, S. lividans, M. luteus ATCC9341, E. coli NIHJ
JC-2, S. cerevisiae S100, C. albicans A9540, and P. chrysogenum at
0.04 mg/5 mm disc on Luria broth glucose agar medium (1% tryptone, 0.5%
yeast extract, 1% NaCl, 0.5% glucose, 1.5% agar) at 30C for 3 days.
Effect of lactazoles for alkaline phosphatase activity in bone morphogenetic
protein-treated C2C12 (R206H) cell was assayed to determine the inhibition of
osteoblastic differentiation as described previously (Fukuda et al., 2012).
Increase of Lactazole A Production by Promoter Substitution
The fragments of the lactazole biosynthetic gene cluster and pTYM3ga for a
vector were amplified using four sets of primers as follows: TYM3ga+
lazA(Nde) and lazD-up-primer, lazD-down-primer and lazF+TYM3ga(Bam)-r,
lazF+TYM3ga(Bam) and TYM3ga_div_at_apr-oriT_forGA-r, TYM3ga_div_at_
apr-oriT_forGA and TYM3ga+lazA(Nde)-r. The generated four fragments
were assembled by Gibson assembly (Gibson et al., 2009) to generate
pTYM3ga-lazAF. pTYM3ga is an actinomycetes-E. coli integrating vector
containing 4K38-1 integrase, apramycin-resistant gene acc(3)IV, and godA
promoter. S. lividans TK23 was transformed with pTYM3ga-lazAF to
generate the laz cluster-promoter substituted strain, S. lividans gp-lazAF.
The strain was incubated in GS medium for 5 to 10 days, and lactazole A
was detected by HPLC (Agilent Technologies 1200 series, using Cosmosil
5C18-AR-II, 5 mm, 4.6 mm inside diameter 3 250 mm) after extraction as
described above. The amount of lactazole A was quantified from the intensity
of the peak.
Analog Production of Lactazole A by Amino Acid Substitution
For lazA mutagenesis, site-directed mutagenesis was carried out using the
QuikChange site-direct mutagenesis kit (Stratagene) with pTYM1ga-lazA
using QC-lazA-S11C-sense, QC-lazA-S11C-anti, QC-lazA-W2S-sense, and
QC-lazA-W2S-anti to generate pTYM1ga-lazAS11C and pTYM1ga-lazAW2S,
respectively. pTYM19 gt-lazBF in which lazB-F was expressed by godA pro-
moter was constructed and transferred in S. lividans TK23 to generate
S. lividans lazBF. To construct pTYM19 gt-lazBF, pTYM3ga-lazBF was first
constructed by Gibson assembly from four PCR fragments using four sets of
primers as follows: TYM3ga+lazB(Nde) and lazD-up-primer, lazD-down-
primer and lazF+TYM3ga(Bam)-r, lazF+TYM3ga(Bam) and TYM3ga_div_at_
apr-oriT_forGA-r, TYM3ga_div_at_apr-oriT_forGA and TYM3ga+lazB(Nde)-r.
Subsequently, pTYM1ga-lazAS11C and pTYM1ga-lazAW2S were transferred
in S. lividans lazBF to generate S. lividans S11C and S. lividans W2S,
respectively.
ACCESSION NUMBERS
The sequence of laz cluster has been deposited in the DDBJ database (acces-
sion number AB820694).
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